Bioeconomy Capital
North America, Washington, United States, Seattle
Description
Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution.
Investor Profile
Bioeconomy Capital has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 31% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Life Science, Pharmaceutical.
Stage Focus
- Series A (44%)
- Series B (25%)
- Seed (19%)
- Series C (6%)
- Series Unknown (6%)
Country Focus
- United States (81%)
- United Kingdom (19%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Life Science
- Pharmaceutical
- Software
- Bioinformatics
- Genetics
- Analytics
- Industrial Automation
- Information Services
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Bioeconomy Capital frequently co-invest with?
What are some of recent deals done by Bioeconomy Capital?
Find More Investors Like Bioeconomy Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
